DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00995449 (ClinicalTrials.gov)	January 2010	5/10/2009	Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis	A Phase 2, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of the Anti-GM-CSF Monoclonal Antibody KB003 in Subjects With Active Rheumatoid Arthritis and Inadequate Prior Treatment Outcome From Biologic Therapy	Rheumatoid Arthritis	Biological: KB003;Other: Placebo Comparator	KaloBios Pharmaceuticals	NULL	Terminated	18 Years	N/A	All	9	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00995449
(ClinicalTrials.gov)

January 2010

5/10/2009

Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis

A Phase 2, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of the Anti-GM-CSF Monoclonal Antibody KB003 in Subjects With Active Rheumatoid Arthritis and Inadequate Prior Treatment Outcome From Biologic Therapy

Rheumatoid Arthritis

Biological: KB003;Other: Placebo Comparator

KaloBios Pharmaceuticals

NULL

Terminated

18 Years

N/A

All

Phase 2

United States